BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 21928704)

  • 1. Potential aspects of chitosan as pharmaceutical excipient.
    Ray SD
    Acta Pol Pharm; 2011; 68(5):619-22. PubMed ID: 21928704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The safety of chitosan as a pharmaceutical excipient.
    Baldrick P
    Regul Toxicol Pharmacol; 2010 Apr; 56(3):290-9. PubMed ID: 19788905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chitosan: a unique polysaccharide for drug delivery.
    Felt O; Buri P; Gurny R
    Drug Dev Ind Pharm; 1998 Nov; 24(11):979-93. PubMed ID: 9876553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chitosan-based gastroretentive floating drug delivery technology: an updated review.
    Pahwa R; Saini N; Kumar V; Kohli K
    Expert Opin Drug Deliv; 2012 May; 9(5):525-39. PubMed ID: 22444200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Applications of chitosan and its derivatives in pharmaceutical industry of Chinese medicine].
    Wang LH; Wu GL; Cheng YY
    Zhongguo Zhong Yao Za Zhi; 2004 Apr; 29(4):289-92. PubMed ID: 15706858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chitosan-based controlled porosity osmotic pump for colon-specific delivery system: screening of formulation variables and in vitro investigation.
    Liu H; Yang XG; Nie SF; Wei LL; Zhou LL; Liu H; Tang R; Pan WS
    Int J Pharm; 2007 Mar; 332(1-2):115-24. PubMed ID: 17052871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential prospects of chitosan derivative trimethyl chitosan chloride (TMC) as a polymeric absorption enhancer: synthesis, characterization and applications.
    Sahni JK; Chopra S; Ahmad FJ; Khar RK
    J Pharm Pharmacol; 2008 Sep; 60(9):1111-9. PubMed ID: 18718113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmaceutical excipient development: the need for preclinical guidance.
    Baldrick P
    Regul Toxicol Pharmacol; 2000 Oct; 32(2):210-8. PubMed ID: 11067777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Niosomes in sustained and targeted drug delivery: some recent advances.
    Azeem A; Anwer MK; Talegaonkar S
    J Drug Target; 2009 Nov; 17(9):671-89. PubMed ID: 19845484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chitosan-based drug delivery systems.
    Bernkop-Schnürch A; Dünnhaupt S
    Eur J Pharm Biopharm; 2012 Aug; 81(3):463-9. PubMed ID: 22561955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stabilizing protein formulations during air-jet nebulization.
    Albasarah YY; Somavarapu S; Taylor KM
    Int J Pharm; 2010 Dec; 402(1-2):140-5. PubMed ID: 20933073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new approach to the safety assessment of pharmaceutical excipients. The Safety Committee of the International Pharmaceutical Excipients Council.
    Steinberg M; Borzelleca JF; Enters EK; Kinoshita FK; Loper A; Mitchell DB; Tamulinas CB; Weiner ML
    Regul Toxicol Pharmacol; 1996 Oct; 24(2 Pt 1):149-54. PubMed ID: 8933628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential applications of chitosan in veterinary medicine.
    Senel S; McClure SJ
    Adv Drug Deliv Rev; 2004 Jun; 56(10):1467-80. PubMed ID: 15191793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid excipients and delivery systems for pharmaceutical development: a regulatory perspective.
    Chen ML
    Adv Drug Deliv Rev; 2008 Mar; 60(6):768-77. PubMed ID: 18077051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chitosan and its use as a pharmaceutical excipient.
    Illum L
    Pharm Res; 1998 Sep; 15(9):1326-31. PubMed ID: 9755881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chitin and chitosan as direct compression excipients in pharmaceutical applications.
    Badwan AA; Rashid I; Omari MM; Darras FH
    Mar Drugs; 2015 Mar; 13(3):1519-47. PubMed ID: 25810109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Excipient pharmacokinetics and profiling.
    Loftsson T
    Int J Pharm; 2015 Mar; 480(1-2):48-54. PubMed ID: 25596414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of chitosan acetate as a binder for sustained release tablets.
    Nunthanid J; Laungtana-Anan M; Sriamornsak P; Limmatvapirat S; Puttipipatkhachorn S; Lim LY; Khor E
    J Control Release; 2004 Sep; 99(1):15-26. PubMed ID: 15342177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thiolated chitosans: useful excipients for oral drug delivery.
    Werle M; Bernkop-Schnürch A
    J Pharm Pharmacol; 2008 Mar; 60(3):273-81. PubMed ID: 18284806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmaceutical applications of cyclodextrins: basic science and product development.
    Loftsson T; Brewster ME
    J Pharm Pharmacol; 2010 Nov; 62(11):1607-21. PubMed ID: 21039545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.